Bifunctional injectable hydrogel with biological properties as well as preparation method and application thereof
By encapsulating the bifunctional hydrogel of multi-walled carbon nanotubes and Prussian blue nanoparticles by sodium alginate, the microenvironment and electrophysiological distribution of the myocardial infarction zone is improved, and the problem of inability to effectively repair and prevent cardiac function deterioration in myocardial infarction treatment is solved. , achieving improved cardiomyocyte survival rate and improved cardiac rhythm stability.
Patent Information
- Application Number
- CN202411121689.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-15
- Publication Date
- 2024-11-19
AI Technical Summary
The existing treatment methods for myocardial infarction cannot effectively reverse the early microenvironment of myocardial infarction, promote myocardial repair and prevent cardiac function deterioration, especially the infarction area of myocardial cells and reduce lethal arrhythmias caused by local high resistance.
Using a dual-function injectable hydrogel with packaged multi-walled carbon nanotubes and Prussian blue nanoparticles based on sodium alginate, the antioxidant performance of Prussian blue nanoparticles improves the conductivity of the myoxidative microenvironment and multi-walled carbon nanotubes. Electrophysiological distribution to form a bifunctional hydrogel with biological properties.
It improves the survival rate of cardiomyocytes in the infarct area, improves myocardial repair ability, and prevents cardiac rhythm disorders through conductive properties, thus providing a new cardiac tissue engineering strategy and solving the single repair disadvantages of traditional therapies.
Smart Images

Figure CN118976150A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biomaterials, and in particular relates to a dual-functional injectable hydrogel with biological properties and a preparation method and application thereof. Background Art
[0002] As my country's aging population intensifies, the burden of cardiovascular diseases will continue to increase, which poses a huge challenge to my country's cardiovascular disease prevention and treatment strategies and medical resource allocation. Among them, coronary heart disease and the myocardial infarction it causes are the most harmful among various cardiovascular diseases.
[0003] More specifically, cardiac cells mainly include cardiomyocytes, fibroblasts, endothelial cells, immune cells, etc. Heart function depends on the healthy and orderly combination of the above cells. The coronary arteries are the main nutrient vessels for the heart. Stenosis or even occlusion of the coronary arteries will cause myocardial infarction, which is a fatal blow to the heart. Millions of cardiomyocytes die immediately after myocardial infarction. At the same time, the expansion and regeneration capacity of cardiomyocytes in the terminal differentiation stage is extremely limited, resulting in the inability of damaged myocardial tissue to repair itself and compensate for the heart's contractile function after infarction. The massive loss of cardiomyocytes will cause the orderly myocardial tissue to be replaced by scar tissue, which will eventually destroy the mechanical properties of the myocardial tissue and impair the transmission of cardiac electrical signals.
[0004] In this case, although traditional drugs and interventional therapies can restore myocardial blood supply and improve cardiac function to a certain extent, existing treatments cannot establish an appropriate microenvironment for myocardial ischemia healing, thereby reversing injured myocardium and dysfunctional heart. Over the years, with the advancement of tissue engineering technology, cardiac tissue engineering strategies based on biomaterials to improve the microenvironment of the infarct area are expected to address the shortcomings of the above-mentioned therapies and are considered to be a potential therapeutic strategy for ischemic heart disease. How to use biomaterials to reverse the early microenvironment of myocardial infarction and further give them the ability to promote repair is the key to improving treatment outcomes.
[0005] With the advancement of medical technology, blood supply to the infarcted area can be restored clinically through intravascular stent implantation and thrombolytic and anticoagulant drug therapy, surviving myocardial tissue can be saved, and cardiac function recovery can be promoted. Coronary artery bypass grafting can be performed for some patients, including those with stent implantation failure, restenosis, ineffective drug treatment, and patency of the distal end of stenosis. Currently, a large number of myocardial infarction patients have been able to survive. However, for patients who further deteriorate into heart failure, although heart transplantation is the gold standard for the treatment of advanced heart failure, its clinical application is limited by the shortage of donor sources and strong postoperative immune rejection reactions.
[0006] Given such a severe clinical situation, how to inhibit ventricular remodeling, further reduce lethal arrhythmias, and prevent further deterioration of cardiac function into heart failure has always been the focus and difficulty of clinical work on myocardial infarction. Although current treatment strategies can restore myocardial blood supply and improve cardiac function to a certain extent, they cannot increase vascularization in the infarcted area, allow myocardial regeneration in the infarcted area, prevent ventricular remodeling, and rebuild the integrity of cardiac electrical conduction. The ideal strategy should be to increase the number of myocardial cells in the infarcted area while reducing arrhythmias caused by local high resistance.
[0007] Therefore, the technical solution of the present invention is proposed. Summary of the invention
[0008] In order to solve the problems existing in the prior art, the present invention provides a method for preparing a dual-functional injectable hydrogel with biological properties, the preparation method comprising the following steps:
[0009] (1) polyvinyl pyrrolidone (PVP) and potassium ferrocyanide (K3[Fe(CN)6]·3H2O) are dispersed in an organic solution, reacted under heating conditions, and then dried to obtain Prussian blue nanoparticles (PBNP);
[0010] (2) dissolving the Prussian blue nanoparticles in water and then dialyzing to obtain a dialyzed Prussian blue nanoparticle solution;
[0011] (3) Weighing the sodium alginate solution, adding the carbon nanotube suspension and the dialyzed Prussian blue nanoparticle solution under vortex conditions, and finally adding the calcium gluconate solution, and obtaining the dual-function injectable hydrogel with biological properties after gelation.
[0012] Preferably, in step (1), the mass ratio of polyvinyl pyrrolidone to potassium ferrocyanide is 1:0.15-0.2.
[0013] Preferably, in step (1), the organic solution is a 75% ethanol aqueous solution containing 0.1 mol / L HCl.
[0014] Preferably, in step (1), the reaction temperature is 80-82° C., and the reaction time is 20-22 h.
[0015] Preferably, in step (2), the dialysis method is: dissolving the Prussian blue nanoparticles in water to obtain a Prussian blue nanoparticle solution; then transferring the Prussian blue nanoparticle solution to a dialysis membrane, and finally dialyzing in a 0.1wt.% PBS solution to obtain a dialyzed Prussian blue nanoparticle solution.
[0016] Preferably, the specification of the dialysis membrane is: MWCO=12-14kD.
[0017] Preferably, in step (3), the concentration of the sodium alginate solution is 3-4 wt%;
[0018] and / or, the concentration of the carbon nanotube suspension is 15-16 mg / mL;
[0019] and / or, the concentration of the dialyzed Prussian blue nanoparticle solution is 5 to 6 mg / mL;
[0020] And / or, the concentration of the calcium gluconate solution is 3-4wt%.
[0021] Based on the same technical concept, another embodiment of the present invention is to provide a dual-functional injectable hydrogel with biological properties obtained by the above preparation method.
[0022] Based on the same technical concept, another solution of the present invention is to provide a bifunctional injectable hydrogel with biological properties for use in the field of preparing myocardial infarction repair materials.
[0023] The beneficial effects of the present invention are:
[0024] The present invention provides a bifunctional injectable hydrogel encapsulating multi-walled carbon nanotubes and Prussian blue nanoparticles based on sodium alginate, which exerts multiple functions through dual mechanisms. The antioxidant properties of Prussian blue nanoparticles improve the myocardial infarction microenvironment, increase the survival rate of myocardial cells in the infarcted area, and thus improve the myocardial repair ability. At the same time, the conductive properties of multi-walled carbon nanotubes are used to improve the uneven electrophysiological distribution and prevent cardiac arrhythmias, fundamentally solving the drawbacks of single repair of traditional therapies in the treatment of myocardial infarction and providing a new strategy for cardiac tissue engineering. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0026] Figure 1 This is a transmission electron microscope photograph of the Prussian blue nanoparticles obtained in Example 1.
[0027] Figure 2 These are actual photos of hydrogels (from left to right: PBNP-Alg, MWCNT-PBNP-Alg, and MWCNT-Alg).
[0028] Figure 3 This is a data graph showing the results of the conductivity test in the effect verification example.
[0029] Figure 4 This is a data graph of the trypan blue staining test results in the effect verification example.
[0030] Figure 5 This is a data chart of CCK-8 test results in the effect verification example.
[0031] Figure 6 This is a data chart of the efficacy test results on myocardial cells damaged by hypoxia in the effect verification example.
[0032] Figure 7 This is a data graph of the in vitro biodegradability regression equation in the effect verification example.
[0033] Figure 8 This is the in vitro biodegradation rate data chart in the effect verification example.
[0034] Fig. 9 This is a graph showing in vivo biodegradability data in an efficacy verification example. DETAILED DESCRIPTION
[0035] To make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be described in detail below. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other implementation methods obtained by ordinary technicians in this field without creative work belong to the scope of protection of the present invention.
[0036] Example 1
[0037] This embodiment provides a method for preparing a dual-function injectable hydrogel with biological properties, the preparation method comprising the following steps:
[0038] (I) Preparation of Prussian blue nanoparticles (PBNP)
[0039] (1) Under magnetic stirring, 1g of PVP (Aladdin, Shanghai, China, P274371) and 0.15g of K3[Fe(CN)6]·3H2O were dispersed in 75% ethanol aqueous solution (10mL) containing 0.1mol / L HCl for 0.5h. Then, the beaker containing the fully mixed solution was covered with a tin foil cover and transferred to an electric oven at 80°C for 20 hours. After drying, a layer of precipitate will form at the bottom of the beaker. It can be scraped off with a small shovel and stored in a centrifuge tube to obtain PBNP (transmission electron microscopy image as shown in the figure). Figure 1 shown).
[0040] (II) Dialysis of PBNP
[0041] (2) dissolving the PBNP in ultrapure water to obtain a PBNP solution, transferring the PBNP solution to a dialysis membrane, and finally dialyzing the solution in a 0.1 wt.% PBS solution to obtain a dialyzed Prussian blue nanoparticle solution;
[0042] The specific dialysis method is: according to the amount of PBNP solution, estimate and cut the dialysis membrane of appropriate length (manufacturer is Spectrum laboratories, product number is 132678T, batch number is 20051803), then moisten the dialysis membrane with water to make it soft, and then blow the dialysis membrane into a cylinder through a pipette, and then tie a knot at the lower end of the dialysis membrane and tighten it, and then use a pipette to absorb the PBNP solution into the dialysis membrane, and then tie a knot at the upper end and tighten it, and finally place the dialysis membrane containing the PBNP solution in a large beaker filled with 0.1wt.% PBS solution on a magnetic stirrer at a speed of 500r / min for stirring and dialysis, and replace the dialysate outside the dialysis membrane twice every two hours. After the second water change and the third water change overnight, it can be found that the solution is no longer yellowish and discolored, and is stable and clear, and the dialysis is judged to be over.
[0043] (III) Preparation of hydrogel
[0044] (3) Multi-walled carbon nanotubes (Boyu Hi-Tech, IM6) were dissolved in ultrapure water and dispersed by ultrasonic vibration to obtain a multi-walled carbon nanotube suspension with a concentration of 15 mg / mL.
[0045] (4) Sodium alginate (McLean, C15314960) was dissolved in ultrapure water, and then stirred thoroughly with a magnetic stirrer to obtain a sodium alginate solution with a concentration of 3 wt.%.
[0046] (5) Calcium gluconate (McLean, C15117047) was dissolved in ultrapure water and then stirred thoroughly with a magnetic stirrer to obtain a calcium gluconate solution with a concentration of 3 wt.%.
[0047] (6) First, 3 mL of sodium alginate solution was added to a 15 mL centrifuge tube, and then 1 mL of carbon nanotube suspension and 1 mL of dialyzed Prussian blue nanoparticle solution (5 mg / mL) were added dropwise while vortexing the sodium alginate solution. Finally, 1.25 mL of calcium gluconate solution was added dropwise while vortexing. The solution formed a gel almost immediately and completely solidified within one minute, thus obtaining a dual-functional injectable hydrogel (MWCNT-PBNP-Alg) with biological properties.
[0048] Its photos are as follows Figure 2 shown.
[0049] Example 2
[0050] This embodiment provides a method for preparing a dual-function injectable hydrogel with biological properties, the preparation method comprising the following steps:
[0051] (I) Preparation of Prussian blue nanoparticles (PBNP)
[0052] (1) Under magnetic stirring, 1 g of PVP (Aladdin, Shanghai, China, P274371) and 0.2 g of K3[Fe(CN)6]·3H2O were dispersed in 75% ethanol aqueous solution (10 mL) containing 0.1 mol / L HCl for 0.5 h. Then, the beaker containing the fully mixed solution was covered with a tin foil cover and transferred to an electric oven at 82°C for 22 h. After drying, a layer of precipitate will form at the bottom of the beaker. It can be scraped off with a small shovel and stored in a centrifuge tube to obtain PBNP.
[0053] (II) Dialysis of PBNP
[0054] (2) dissolving the PBNP in ultrapure water to obtain a PBNP solution, transferring the PBNP solution to a dialysis membrane, and finally dialyzing the solution in a 0.1 wt.% PBS solution to obtain a dialyzed Prussian blue nanoparticle solution;
[0055] The specific dialysis method is: according to the amount of PBNP solution, estimate and cut the dialysis membrane of appropriate length (manufacturer is Spectrum laboratories, product number is 132678T, batch number is 20051803), then moisten the dialysis membrane with water to make it soft, and then blow the dialysis membrane into a cylinder through a pipette, and then tie a knot at the lower end of the dialysis membrane and tighten it, and then use a pipette to absorb the PBNP solution into the dialysis membrane, and then tie a knot at the upper end and tighten it, and finally place the dialysis membrane containing the PBNP solution in a large beaker filled with 0.1wt.% PBS solution on a magnetic stirrer at a speed of 300r / min for stirring and dialysis, and replace the dialysate outside the dialysis membrane twice every two hours. After the second water change and the third water change overnight, it can be found that the solution is no longer yellowish and discolored, and is stable and clear, and the dialysis is judged to be over.
[0056] (III) Preparation of hydrogel
[0057] (3) Multi-walled carbon nanotubes (Boyu Hi-Tech, IM6) were dissolved in ultrapure water and dispersed by ultrasonic vibration to obtain a multi-walled carbon nanotube suspension with a concentration of 16 mg / mL.
[0058] (4) Sodium alginate (McLean, C15314960) was dissolved in ultrapure water, and then stirred thoroughly with a magnetic stirrer to obtain a sodium alginate solution with a concentration of 4 wt.%.
[0059] (5) Calcium gluconate (McLean, C15117047) was dissolved in ultrapure water and then stirred thoroughly with a magnetic stirrer to obtain a calcium gluconate solution with a concentration of 4 wt.%.
[0060] (6) First, 3 mL of sodium alginate solution was added to a 15 mL centrifuge tube. Then, 1 mL of carbon nanotube suspension and 1 mL of dialyzed Prussian blue nanoparticle solution (6 mg / mL) were added dropwise while the sodium alginate solution was vortexed. Finally, 1.25 mL of calcium gluconate solution was added dropwise while vortexing. The solution was gelled almost immediately and completely solidified within one minute, thereby obtaining a dual-functional injectable hydrogel with biological properties.
[0061] Comparative Example 1
[0062] This comparative example 1 provides a method for preparing a multi-walled carbon nanotube hydrogel, which comprises the following steps:
[0063] First, add 3mL of sodium alginate solution to a 15mL centrifuge tube, then add 1mL of multi-walled carbon nanotube suspension while vortexing the sodium alginate solution, and finally add 1mL of calcium gluconate solution while vortexing. It will basically gel immediately and completely solidify within one minute to obtain multi-walled carbon nanotube hydrogel (MWCNT-Alg). (The above solutions should be vortexed before use. It is better to use a 1mL syringe to extract the carbon nanotube suspension, and a 1mL gun tip can be used for the rest).
[0064] The concentration of the raw materials used in Comparative Example 1 is the same as that in Example 1.
[0065] Its photos are as follows Figure 2 shown.
[0066] Comparative Example 2
[0067] This comparative example 2 provides a method for preparing a Prussian blue hydrogel, which comprises the following steps:
[0068] First, 3 mL of sodium alginate solution was added to a 15 mL centrifuge tube, and then 1 mL of Prussian blue solution was added dropwise while the sodium alginate solution was vortexed, and finally 1 mL of calcium gluconate solution was added dropwise while vortexing. The solution was gelled almost immediately and completely solidified within one minute to obtain Prussian blue hydrogel (PBNP-Alg).
[0069] The concentration of the raw materials used in Comparative Example 2 is the same as that in Example 1.
[0070] Its photos are as follows Figure 2 shown.
[0071] Effect verification example
[0072] (I) Conductivity test
[0073] Test subjects:
[0074] (i) MWCNT-PBNP-Alg, which is the dual-functional injectable hydrogel with biological properties prepared in Example 1.
[0075] (ii) MWCNT-Alg, which is the multi-walled carbon nanotube hydrogel prepared in Comparative Example 1.
[0076] (iii) PBNP-Alg, which is the Prussian blue hydrogel prepared in Comparative Example 2.
[0077] (iv) 1.44 wt% Alg, 1.44 wt% Alg means that 3 wt% Alg is diluted to 1.44 wt% Alg in the mixed system of MWCNT-PBNP-Alg, so pure 1.44 wt% Alg is used as one of the controls of MWCNT-PBNP-Alg to measure the conductivity.
[0078] This test uses the four-probe method to test four groups of products. The results are as follows Figure 3 As shown by Figure 3 It can be seen that the conductivity of the MWCNT-PBNP-Alg group is 5.10588 (×10 -5 s / cm), and the conductivity of MWCNT-Alg group is 5.41462(×10 -5 s / cm), and the conductivity of PBNP-Alg group was 1.91926(×10 -5 s / cm), and the conductivity of 1.44wt%Alg group is 0.565652(×10 -5 s / cm).
[0079] There was no statistical difference in conductivity between the MWCNT-PBNP-Alg group and the MWCNT-Alg group (ns means no statistical difference), and there was a significant difference between the MWCNT-PBNP-Alg group and the 1.44wt%Alg group (**** means P<0.0001). This shows that the MWCNT-PBNP-Alg group has the same excellent conductivity as the MWCNT-Alg group, and the 1.44wt%Alg group itself has no conductivity, while the MWCNT-PBNP-Alg group with the addition of the conductive component MWCNT has a significant improvement in conductivity.
[0080] (II) Biocompatibility test
[0081] Test subjects:
[0082] (i) MWCNT-PBNP-Alg, which is the dual-functional injectable hydrogel with biological properties prepared in Example 1.
[0083] (ii) MWCNT-Alg, which is the multi-walled carbon nanotube hydrogel prepared in Comparative Example 1.
[0084] (iii) PBNP-Alg, which is the Prussian blue hydrogel prepared in Comparative Example 2.
[0085] (iv) Control group: The control group refers to culture H9C2 and HUVEC in DMEM-Hg medium without adding other components.
[0086] First, the trypan blue staining method was used to test the Figure 4 As shown by Figure 4 It can be seen that trypan blue staining and counting showed that there was no statistical difference (ns, not significant) between the MWCNT-PBNP-Alg group and the control group, PBNP-Alg group, and MWCNT-Alg group, proving that the MWCNT-PBNP-Alg hydrogel has good biocompatibility for both cells.
[0087] Then the CCK-8 method was used for testing, and the results were as follows Figure 5 As shown by Figure 5 It can be seen that the CCK-8 method showed that there was no statistical difference in the cell viability of the two cells cultured in the MWCNT-PBNP-Alg group compared with the cell viability of the two cells cultured in the control group, PBNP-Alg group, and MWCNT-Alg group (ns, not significant), proving that the MWCNT-PBNP-Alg hydrogel has good biocompatibility for both cells.
[0088] 3. Detection of therapeutic efficacy on hypoxic damaged cardiomyocytes
[0089] (i) MWCNT-PBNP-Alg, which is the dual-functional injectable hydrogel with biological properties prepared in Example 1.
[0090] (ii) MWCNT-Alg, which is the multi-walled carbon nanotube hydrogel prepared in Comparative Example 1.
[0091] (iii) PBNP-Alg, which is the Prussian blue hydrogel prepared in Comparative Example 2.
[0092] (iv) Sham operation group, refers to H9C2 cells cultured in DMEM-Hg medium without other active ingredients immediately after being exposed to H2O2 for 5 minutes.
[0093] (v) Control group, refers to H9C2 cells cultured in DMEM-Hg medium without other active ingredients immediately after being damaged by H2O2 for 4 hours.
[0094] Test results such as Figure 6 As shown by Figure 6It can be seen that the MWCNT-PBNP-Alg group has a significant difference compared with the control group (** means P<0.01). Therefore, after detecting the cell viability of each group by CCK-8 method and comparing it with the sham operation group, it can be seen that MWCNT-PBNP-Alg hydrogel has a good therapeutic effect on hypoxic damaged cardiomyocytes.
[0095] (IV) Biodegradability test
[0096] Test subjects:
[0097] (i) MWCNT-PBNP-Alg, which is the dual-functional injectable hydrogel with biological properties prepared in Example 1.
[0098] (ii) MWCNT-Alg, which is the multi-walled carbon nanotube hydrogel prepared in Comparative Example 1.
[0099] (iii) PBNP-Alg, which is the Prussian blue hydrogel prepared in Comparative Example 2.
[0100] First, the in vitro biodegradability line graphs of the three hydrogels were drawn by continuous weighing of EP tubes, that is, 500 μL of different groups of hydrogels were added to 1.5 mL EP tubes, and five replicates were performed for each group. The tubes were sealed with sealing film. The EP tubes were weighed every two days. Figure 7 It can be seen that according to the regression equations of the three groups, MWCNT-PBNP-Alg hydrogel has good biodegradability.
[0101] The in vitro biodegradation rate comparison chart of the three hydrogels was drawn by the EP tube continuous weighing method (i.e., the weight on the 30th day minus the weight on the zeroth day divided by the weight on the zeroth day, and the obtained ratio is the degradation rate), as shown in Figure 8 As shown: the degradation rate of MWCNT-PBNP-Alg is 0.00577377, the degradation rate of PBNP-Alg is 0.0101174, and the degradation rate of MWCNT-Alg is 0.00677508.
[0102] It should be noted that * means there is a small difference between the degradation rate of PBNP-Alg and MWCNT-PBNP-Alg, P < 0.05; ns means there is no statistical difference between the degradation rate of MWCNT-Alg and MWCNT-PBNP-Alg.
[0103] The degradation rate of the PBNP-Alg group is too high. Although it can ensure that it will not cause long-term retention in the body and will not become a long-term xenograft, there is also a risk of degradation too fast to exert the therapeutic effect. Therefore, the MWCNT-PBNP-Alg with a medium degradation rate is more practical, which once again verifies that the MWCNT-PBNP-Alg hydrogel has good and practical biodegradability.
[0104] The above three hydrogels are injected into the back of the hydrogel circle diameter from the zeroth day to the seventh day to the fourteenth day to the twenty-first day to the twenty-eighth day and then to the broken line. That is, with the help of a ruler, three hydrogel protrusions arranged in a row were injected into the back of each group of SD rats, and then their diameters were measured every seven days. The broken line was drawn according to the change in diameter size, and the diameter was tracked and measured every fourteen days after the twenty-eighth day until all returned to zero. Fig. 9 It can be seen from the line graph that from the 0th day to the 28th day, each group has obvious biodegradation, and the PBNP-Alg group has the best degradation, followed by the MWCNT-PBNP-Alg group. After the 28th day, the degradation trend tends to be gentle.
[0105] The above is only a specific embodiment of the present invention, but the protection scope of the present invention is not limited thereto. Any person skilled in the art can easily think of changes or substitutions within the technical scope disclosed by the present invention, which should be included in the protection scope of the present invention. Therefore, the protection scope of the present invention should be based on the protection scope of the claims.
Claims
1. A method for preparing a bifunctional injectable hydrogel with biological properties, characterized in that: The preparation method comprises the following steps: (1) dispersing polyvinyl pyrrolidone and potassium ferrocyanide in an organic solution, reacting under heating conditions, and then drying to obtain Prussian blue nanoparticles; (2) dissolving the Prussian blue nanoparticles in water and then dialyzing to obtain a dialyzed Prussian blue nanoparticle solution; (3) Weighing the sodium alginate solution, adding the carbon nanotube suspension and the dialyzed Prussian blue nanoparticle solution under vortex conditions, and finally adding the calcium gluconate solution, and obtaining the dual-function injectable hydrogel with biological properties after gelation.
2. The method for preparing the bifunctional injectable hydrogel with biological properties according to claim 1, characterized in that: In step (1), the mass ratio of polyvinyl pyrrolidone to potassium ferrocyanide is 1:0.15-0.
2.
3. The method for preparing the bifunctional injectable hydrogel with biological properties according to claim 1, characterized in that: In step (1), the organic solution is a 75% ethanol aqueous solution containing 0.1 mol / L HCl.
4. The method for preparing the bifunctional injectable hydrogel with biological properties according to claim 1, characterized in that: In step (1), the reaction temperature is 80-82° C., and the reaction time is 20-22 h.
5. The method for preparing the bifunctional injectable hydrogel with biological properties according to claim 1, characterized in that: In step (2), the dialysis method is: dissolving the Prussian blue nanoparticles in water to obtain a Prussian blue nanoparticle solution; then transferring the Prussian blue nanoparticle solution to a dialysis membrane, and finally dialyzing in a 0.1wt.% PBS solution to obtain a dialyzed Prussian blue nanoparticle solution.
6. The method for preparing the bifunctional injectable hydrogel with biological properties according to claim 5, characterized in that: The specification of the dialysis membrane is: MWCO=12-14KD.
7. The method for preparing the bifunctional injectable hydrogel with biological properties according to claim 1, characterized in that: In step (3), the concentration of the sodium alginate solution is 3-4 wt %; and / or, the concentration of the carbon nanotube suspension is 15-16 mg / mL; and / or, the concentration of the dialyzed Prussian blue nanoparticle solution is 5 to 6 mg / mL; And / or, the concentration of the calcium gluconate solution is 3-4wt%.
8. The bifunctional injectable hydrogel with biological properties obtained by the preparation method according to any one of claims 1 to 7.
9. Use of the bifunctional injectable hydrogel with biological properties as claimed in claim 8 in the field of preparing myocardial infarction repair materials.
